(NASDAQ: LIVN) Livanova's forecast annual revenue growth rate of 7.87% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.98%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.1%.
Livanova's revenue in 2026 is $1,388,053,000.On average, 14 Wall Street analysts forecast LIVN's revenue for 2026 to be $83,347,371,024, with the lowest LIVN revenue forecast at $79,792,529,084, and the highest LIVN revenue forecast at $86,410,004,080. On average, 14 Wall Street analysts forecast LIVN's revenue for 2027 to be $88,871,048,500, with the lowest LIVN revenue forecast at $83,566,130,528, and the highest LIVN revenue forecast at $93,191,548,704.
In 2028, LIVN is forecast to generate $95,543,213,372 in revenue, with the lowest revenue forecast at $88,324,149,740 and the highest revenue forecast at $103,254,485,888.